Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation
Introduction: Oral cancer accounts for approximately 2.1% of all cancers worldwide. In India, oral squamous cell carcinoma (OSCC) is the most common cancer with half a million new cases diagnosed every year. More than 50% of patients eventually develop local recurrence or metastasis usually within t...
Main Authors: | Seema Gupta, Vandana Singh Kushwaha, Sandeep Verma, Huma Khan, M.L.B. Bhatt, Nuzhat Husain, Mahendra Pal Singh Negi, Vivek Vidyadhar Bhosale, Ashim Ghatak |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-12-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844016310519 |
Similar Items
-
A Study to Assess the Dosimetric Impact of the Anatomical Changes Occurring in the Parotid Glands and Tumour Volume during Intensity Modulated Radiotherapy using Simultaneous Integrated Boost (IMRT‐SIB) in Head and Neck Squamous Cell Cancers
by: Arunima Ghosh, et al.
Published: (2021-08-01) -
HPV transcript expression affects cervical cancer response to chemoradiation
by: Fiona J. Ruiz, et al.
Published: (2021-08-01) -
Circulating free DNA as a marker of response to chemoradiation in locally advanced head and neck squamous cell carcinoma
by: Tripti Verma, et al.
Published: (2020-01-01) -
Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation.
by: Mohammad Abbas, et al.
Published: (2015-01-01) -
Chemoradiation for oesophageal cancer: the choice of treatment modality
by: Pauliina M. Kitti, et al.
Published: (2023-05-01)